Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 4Completed 3Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 23Thoracic 8Genitourinary 7Gynecologic 6Breast 6Lymphoid 5Head & Neck 5Sarcoma 4Dermatologic 4CNS 4Tumor-Agnostic 3Other hematologic neoplasm 3Other solid neoplasm 2Other 2Plasma cell 1Myeloid 1Endocrine 1

Conditions

Melanoma 2Carcinoma, Basal Cell 2Skin Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 65Nivolumab 59Ipilimumab 33Cyclophosphamide 23Specimen Handling 16Magnetic Resonance Spectroscopy 15Biopsy 15relatlimab 13fludarabine 13cemiplimab 13Opdualag 12Blood Specimen Collection 11binimetinib 10aldesleukin 9Radiosurgery 9Interleukin-2 9encorafenib 8atezolizumab 7Immunotherapy 7tebentafusp 6mogamulizumab 6fludarabine phosphate 6Temozolomide 6Surgical Procedures, Operative 6Paclitaxel 6Immunoglobulin G 6CTLA-4 Antigen 6Aminolevulinic Acid 6Radiotherapy 5Disulfides 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Observation × Dermatologic × Clear all
NCT06539468 2026-04-14

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

University of Michigan Rogel Cancer Center

Phase NA Recruiting
200 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT06887348 2026-01-12

RPx

Replimune, Inc.

Recruiting
50 enrolled
DermatologicGastrointestinal

Carcinoma, Hepatocellular, Melanoma

NCT05561634 2025-09-30

RADIOSONIC

University Hospital, Lille

Phase 2 Recruiting
82 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT07092670 2025-09-05

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

Intergruppo Melanoma Italiano

Recruiting
270 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡